Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2011 1
2012 1
2013 1
2015 1
2016 1
2017 1
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Foley JF, Defer G, Ryerson LZ, Cohen JA, Arnold DL, Butzkueven H, Cutter G, Giovannoni G, Killestein J, Wiendl H, Smirnakis K, Xiao S, Kong G, Kuhelj R, Campbell N; NOVA study investigators. Foley JF, et al. Lancet Neurol. 2022 Jul;21(7):608-619. doi: 10.1016/S1474-4422(22)00143-0. Epub 2022 Apr 25. Lancet Neurol. 2022. PMID: 35483387 Clinical Trial.
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations.
Rae W, Sowerby JM, Verhoeven D, Youssef M, Kotagiri P, Savinykh N, Coomber EL, Boneparth A, Chan A, Gong C, Jansen MH, du Long R, Santilli G, Simeoni I, Stephens J, Wu K, Zinicola M, Allen HL, Baxendale H, Kumararatne D, Gkrania-Klotsas E, Scheffler Mendoza SC, Yamazaki-Nakashimada MA, Ruiz LB, Rojas-Maruri CM, Lugo Reyes SO, Lyons PA, Williams AP, Hodson DJ, Bishop GA, Thrasher AJ, Thomas DC, Murphy MP, Vyse TJ, Milner JD, Kuijpers TW, Smith KGC. Rae W, et al. Among authors: ruiz lb. Sci Immunol. 2022 Aug 12;7(74):eabn3800. doi: 10.1126/sciimmunol.abn3800. Epub 2022 Aug 12. Sci Immunol. 2022. PMID: 35960817
CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics.
França TT, Barreiros LA, Salgado RC, Napoleão SMDS, Gomes LN, Ferreira JFS, Prando C, Weber CW, Di Gesu RSW, Montenegro C, Aranda CS, Kuntze G, Staines-Boone AT, Venegas-Montoya E, Becerra JCA, Bezrodnik L, Di Giovanni D, Moreira I, Seminario GA, Raccio ACG, Dorna MB, Rosário-Filho NA, Chong-Neto HJ, de Carvalho E, Grotta MB, Orellana JC, Dominguez MG, Porras O, Sasia L, Salvucci K, Garip E, Leite LFB, Forte WCN, Pinto-Mariz F, Goudouris E, Nuñez MEN, Schelotto M, Ruiz LB, Liberatore DI, Ochs HD, Cabral-Marques O, Condino-Neto A. França TT, et al. Among authors: ruiz lb. J Clin Immunol. 2022 Apr;42(3):514-526. doi: 10.1007/s10875-021-01182-5. Epub 2022 Jan 4. J Clin Immunol. 2022. PMID: 34982304
Correction to: CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics.
França TT, Barreiros LA, Salgado RC, da Silva Napoleão SM, Gomes LN, Ferreira JFS, Prando C, Weber CW, Di Gesu RSW, Montenegro C, Aranda CS, Kuntze G, Staines-Boone AT, Venegas-Montoya E, Becerra JCA, Bezrodnik L, Di Giovanni D, Moreira I, Seminario GA, Raccio ACG, de Barros Dorna M, Rosario-Filho NA, Chong-Neto HJ, de Carvalho E, Grotta MB, Orellana JC, Dominguez MG, Porras O, Sasia L, Salvucci K, Garip E, Leite LFB, Forte WCN, Pinto-Mariz F, Goudouris E, Nuñez MEN, Schelotto M, Ruiz LB, Liberatore DI, Ochs HD, Cabral-Marques O, Condino-Neto A. França TT, et al. Among authors: ruiz lb. J Clin Immunol. 2022 Apr;42(3):527-528. doi: 10.1007/s10875-022-01221-9. J Clin Immunol. 2022. PMID: 35129805 No abstract available.
Why are you hitting yourself? Whole-exome sequencing diagnosis of monogenic autoimmunity.
Castano-Jaramillo LM, Larrauri FR, Scheffler-Mendoza SC, Gutierrez-Hernandez A, Ogando JCB, Colin P, Cisneros MO, Rajme-López S, Medina-Torres EA, Ruiz LB, Rodriguez-Lozano AL, Padilla SEE, Yamazaki-Nakashimada MA, Reyes SOL. Castano-Jaramillo LM, et al. Among authors: ruiz lb. J Genet. 2023;102:53. J Genet. 2023. PMID: 38073170 Free article.
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
Sánchez AG, Andrade EL, Marsal JV, Tauste LA, Mingot CG, Monge JL, Puértolas MC, Calero NS, Argemí AS, Badia BG, Moncusí SP, Benito HG, Peñabad LN, Pujol ML, Nieves I Collado M, Ruiz LB. Sánchez AG, et al. Among authors: ruiz lb. Int J Neurosci. 2017 May;127(5):404-411. doi: 10.1080/00207454.2016.1186025. Epub 2016 May 24. Int J Neurosci. 2017. PMID: 27144498 Clinical Trial.
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN.
Martínez-Jañez N, Ezquerra MB, Manso Sanchez LM, Carrasco FH, Torres AA, Morales S, Ortega PT, Gil VLO, Sampedro T, Conejero RA, Calvo-Martinez L, Galve-Calvo E, López R, de la Pena FA, Lopez-Tarruella S, de Araguiz BAHF, Ruiz LB, Cardenas TM, Chacon JI, Antón FM. Martínez-Jañez N, et al. Among authors: ruiz lb. Breast Cancer Res Treat. 2024 Apr 1. doi: 10.1007/s10549-024-07287-w. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38561577
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis.
Devonshire V, Lapierre Y, Macdonell R, Ramo-Tello C, Patti F, Fontoura P, Suchet L, Hyde R, Balla I, Frohman EM, Kieseier BC; GAP Study Group. Devonshire V, et al. Eur J Neurol. 2011 Jan;18(1):69-77. doi: 10.1111/j.1468-1331.2010.03110.x. Eur J Neurol. 2011. PMID: 20561039 Clinical Trial.
Effects of hexavalent chromium in two strains of Euglena gracilis.
Rocchetta I, Ruiz LB, Magaz G, Conforti VT. Rocchetta I, et al. Among authors: ruiz lb. Bull Environ Contam Toxicol. 2003 May;70(5):1045-51. doi: 10.1007/s00128-003-0088-z. Bull Environ Contam Toxicol. 2003. PMID: 12719834 No abstract available.
Urethral catheter-related urinary infection in critical patients admitted to the ICU. Descriptive data of the ENVIN-UCI study.
Alvarez-Lerma F, Gracia-Arnillas MP, Palomar M, Olaechea P, Insausti J, López-Pueyo MJ, Otal JJ, Gimeno R, Seijas I; Grupo de Investigadores del Estudio Nacional de Vigilancia de Infección Nosocomial en UCI. Alvarez-Lerma F, et al. Med Intensiva. 2013 Mar;37(2):75-82. doi: 10.1016/j.medin.2012.02.013. Epub 2012 May 11. Med Intensiva. 2013. PMID: 22579562 Free article. English, Spanish.
12 results